These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7256285)

  • 1. Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure.
    Tackett RL; Webb JG; Privitera PJ
    Science; 1981 Aug; 213(4510):911-3. PubMed ID: 7256285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site and mechanism of the centrally mediated hypotensive action of propranolol.
    Tackett RL; Webb JG; Privitera PJ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):66-70. PubMed ID: 4045728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of DL-propranolol on norepinephrine in cerebrospinal fluid and plasma.
    Lerner P; Major LF; Dendel PS; Ziegler MG
    Brain Res; 1981 Nov; 223(2):444-7. PubMed ID: 7284824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of propranolol with central serotonergic neurons.
    Jones LF; Tackett RL
    Life Sci; 1988; 43(26):2249-55. PubMed ID: 2463453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
    Privitera PJ; Granata AR; Underwood MD; Gaffney TE; Reis DJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):529-33. PubMed ID: 3404445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of centrally administered propranolol on plasma renin activity, plasma norepinephrine and arterial pressure.
    Privitera PJ; Webb JG; Walle T
    Eur J Pharmacol; 1979 Feb; 54(1-2):51-60. PubMed ID: 421742
    [No Abstract]   [Full Text] [Related]  

  • 7. [Central and peripheral mechanisms of hypotension induced by dl-propranolol in the dog].
    Cicardo VH
    Acta Physiol Lat Am; 1978; 28(6):235-42. PubMed ID: 263726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of D- and DL-propranolol on blood pressure and cerebral norepinephrine in rats with DOCA-hypertension.
    Lydtin H; Sommerfeldt H
    Int J Clin Pharmacol; 1972 Nov; 6(4):328-31. PubMed ID: 4641848
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of adrenergic neurone blockade in the hypotensive action of propranolol.
    Eliash S; Weinstock M
    Br J Pharmacol; 1971 Oct; 43(2):287-94. PubMed ID: 4400571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intracisternal application of 6-hydroxydopamine on the antihypertensive action of propranolol in the dog.
    Montastruc JL; Montastruc P
    Eur J Pharmacol; 1980 May; 63(2-3):103-16. PubMed ID: 6247163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of propranolol on plasma norepinephrine during sodium nitroprusside-induced hypotension.
    Dean CR; Maling T; Dargie HJ; Reid JL; Dollery CT
    Clin Pharmacol Ther; 1980 Feb; 27(2):156-64. PubMed ID: 7353333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leakage of dl-propranolol from cerebrospinal fluid to the bloodstream in the rabbit.
    Anderson WP; Korner PI; Bobik A; Chalmers JP
    J Pharmacol Exp Ther; 1977 Aug; 202(2):320-5. PubMed ID: 886469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
    Hom GJ; Jandhyala BS
    J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of peripheral dopamine receptors in the antihypertensive effect of a new ergoline derivative (355/1057).
    Salvati P; Bianchi G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):291-304. PubMed ID: 4026460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central hypotensive activity of dl- and d-propranolol.
    Kelliher GJ; Buckley JP
    J Pharm Sci; 1970 Sep; 59(9):1276-80. PubMed ID: 5469791
    [No Abstract]   [Full Text] [Related]  

  • 16. Free fatty acid mobilization in rats following intracerebroventricular norepinephrine.
    Barbosa MC; Migliorini RH
    Am J Physiol; 1982 Apr; 242(4):E248-52. PubMed ID: 7065239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers.
    Offerhaus L; van Zwieten PA
    Cardiovasc Res; 1974 Jul; 8(4):488-95. PubMed ID: 4426059
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypotensive action of propranolol and a new beta-blocking agent, D-32 in conscious normotensive and renal hypertensive dogs.
    Himori N; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):4-18. PubMed ID: 8021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intracisternal 5,-7-dihydroxytryptamine on the acute antihypertensive action of propranolol in the sino-aortic denervated anaesthetized dog.
    Montastruc JL; Montastruc P
    Br J Pharmacol; 1981 Mar; 72(3):411-7. PubMed ID: 7260484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.